Marquez-Garban D, Yanes C, Llarena G, Elashoff D, Hamilton N, Hardy M
Nutrients. 2024; 16(14).
PMID: 39064812
PMC: 11279598.
DOI: 10.3390/nu16142369.
Zhang Z, Wang W, Kong P, Feng K, Liu C, Sun T
Int J Oncol. 2023; 62(6).
PMID: 37203395
PMC: 10198711.
DOI: 10.3892/ijo.2023.5522.
Isik O, Cizmecioglu O
Adv Exp Med Biol. 2023; 1436:87-108.
PMID: 36648750
DOI: 10.1007/5584_2022_759.
Mauvais-Jarvis F, Lange C, Levin E
Endocr Rev. 2021; 43(4):720-742.
PMID: 34791092
PMC: 9277649.
DOI: 10.1210/endrev/bnab041.
Alemany M
World J Diabetes. 2021; 12(10):1622-1654.
PMID: 34754368
PMC: 8554369.
DOI: 10.4239/wjd.v12.i10.1622.
The Sex-Related Interplay between TME and Cancer: On the Critical Role of Estrogen, MicroRNAs and Autophagy.
Matarrese P, Mattia G, Pagano M, Pontecorvi G, Ortona E, Malorni W
Cancers (Basel). 2021; 13(13).
PMID: 34209162
PMC: 8267629.
DOI: 10.3390/cancers13133287.
Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.
Mollinedo F, Gajate C
J Lipid Res. 2021; 61(5):611-635.
PMID: 33715811
PMC: 7193951.
DOI: 10.1194/jlr.TR119000439.
Sequential Colocalization of ERa, PR, and AR Hormone Receptors Using Confocal Microscopy Enables New Insights into Normal Breast and Prostate Tissue and Cancers.
Chenlo M, Aliyev E, Rodrigues J, Vieiro-Balo P, Blanco Freire M, Cameselle-Teijeiro J
Cancers (Basel). 2020; 12(12).
PMID: 33266334
PMC: 7761237.
DOI: 10.3390/cancers12123591.
Secreted sphingomyelins modulate low mammary cancer incidence observed in certain mammals.
Ledet M, Harman R, Fan J, Schmitt-Matzen E, Diaz-Rubio M, Zhang S
Sci Rep. 2020; 10(1):20580.
PMID: 33239740
PMC: 7689471.
DOI: 10.1038/s41598-020-77639-1.
Spatiotemporal strategies to identify aggressive biology in precancerous breast biopsies.
Frankhauser D, Jovanovic-Talisman T, Lai L, Yee L, Wang L, Mahabal A
WIREs Mech Dis. 2020; 13(2):e1506.
PMID: 33001587
PMC: 8544796.
DOI: 10.1002/wsbm.1506.
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL.
Wulfkuhle J, Yau C, Wolf D, Vis D, Gallagher R, Brown-Swigart L
JCO Precis Oncol. 2020; 2.
PMID: 32914002
PMC: 7446527.
DOI: 10.1200/PO.18.00024.
ERα, A Key Target for Cancer Therapy: A Review.
Liu Y, Ma H, Yao J
Onco Targets Ther. 2020; 13:2183-2191.
PMID: 32210584
PMC: 7073439.
DOI: 10.2147/OTT.S236532.
Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.
Maselli A, Parlato S, Puglisi R, Raggi C, Spada M, Macchia D
Cells. 2019; 8(7).
PMID: 31331091
PMC: 6678306.
DOI: 10.3390/cells8070750.
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.
Marquez-Garban D, Deng G, Comin-Anduix B, Garcia A, Xing Y, Chen H
J Steroid Biochem Mol Biol. 2019; 193:105415.
PMID: 31226312
PMC: 6903431.
DOI: 10.1016/j.jsbmb.2019.105415.
Sex hormone-binding globulin provides a novel entry pathway for estradiol and influences subsequent signaling in lymphocytes via membrane receptor.
Balogh A, Karpati E, Schneider A, Hetey S, Szilagyi A, Juhasz K
Sci Rep. 2019; 9(1):4.
PMID: 30626909
PMC: 6327036.
DOI: 10.1038/s41598-018-36882-3.
Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling.
Cipolletti M, Solar Fernandez V, Montalesi E, Marino M, Fiocchetti M
Int J Mol Sci. 2018; 19(9).
PMID: 30189583
PMC: 6165334.
DOI: 10.3390/ijms19092624.
Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint.
Srivatsav A, Mishra M, Kapoor S
Biomed Res Int. 2018; 2018:6437371.
PMID: 30186863
PMC: 6114229.
DOI: 10.1155/2018/6437371.
C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.
Li W, Xu L, Che X, Li H, Zhang Y, Song N
BMC Cancer. 2018; 18(1):507.
PMID: 29720121
PMC: 5930956.
DOI: 10.1186/s12885-018-4387-5.
Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.
Boonyaratanakornkit V, Hamilton N, Marquez-Garban D, Pateetin P, McGowan E, Pietras R
Mol Cell Endocrinol. 2017; 466:51-72.
PMID: 29146555
PMC: 5878997.
DOI: 10.1016/j.mce.2017.11.010.
7-ketocholesterol and 27-hydroxycholesterol decreased doxorubicin sensitivity in breast cancer cells: estrogenic activity and mTOR pathway.
Wang C, Huang C, Chou P, Chang Y, Wei S, Guengerich F
Oncotarget. 2017; 8(39):66033-66050.
PMID: 29029490
PMC: 5630390.
DOI: 10.18632/oncotarget.19789.